en

PRODUCT DETAIL

Pegasys 180 mikrogramov injekčný roztok

Code 20381
MA number EU/1/02/221/004
Product Form: sol inj 4x1,0 ml (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 Immunomodulators/-stimulants
L03A Immunostimulants
L03AB Interferons
L03AB11 Peginterferon alfa-2a
Shelf life: 48
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 20.06.2002
SmPC + PL: European Medicines Agency's database
Dokument: DHCP Pegasys_falzifikat_26 11 2013.pdf  
Safety feature Yes
Data update: 19.06.2018
eu-flag.png sk-flag.png